Reports

• CMS Should Pursue Strategies To Increase the Number of At Risk Beneficiaries Acquiring Naloxone Through Medicaid

  

• Oregon Oversight Did Not Ensure That Four Coordinated-Care Organizations Complied With Selected Medicaid Requirements Related to Access to Care and Quality of Care

  

• Incorrect Acute Stroke Diagnosis Codes Submitted by Traditional Medicare Providers Resulted in Millions of Dollars in Increased Payments to Medicare Advantage Organizations

  

• Maine Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs

  

• Some Manufacturers Reported Inaccurate Drug Product Data to CMS

  

• Billions in Estimated Medicare Advantage Payments From Diagnoses Reported Only on Health Risk Assessments Raise Concerns

  

• Audit of Medicare Part D Pharmacy Fees: Horizon Blue Cross Blue Shield, Inc.

  

• Colorado Claimed Unsupported and Incorrect Federal Medicaid Reimbursement for Beneficiaries Enrolled in the New Adult Group

  

• Medicare Hospital Provider Compliance Audit: Flagstaff Medical Center

  

• Tribal Health Programs: Concerns About Background Verifications for Staff Working With Indian Children

  

• CMS Generally Met Requirements for the DMEPOS Competitive Bidding Program Round 1 Recompete

  

• Indiana Monitoring Did Not Ensure Child Care Provider Compliance With State Criminal Background Check Requirements at 17 of 30 Providers Reviewed

  

• Michigan Did Not Bill Manufacturers for Some Rebates for Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations

  

• Illinois Claimed Unallowable Telemedicine Payments

  

• Indiana Paid $3.5 Million for Medicaid Nonemergency Medical Transport Claims That Did Not Comply With Federal and State Requirements

  

• Foreign Assistance to Combat HIV/AIDS, Tuberculosis, and Malaria Fiscal Year 2021 Inspectors General Coordinated PEPFAR Oversight Plan U.S. Department of Health and Human Services, Office of Inspector General

  

• Texas Relied on Impermissible Provider-Related Donations To Fund the State Share of the Medicaid Delivery System Reform Incentive Payment Program

  

• Medicare Contractors Were Not Consistent in How They Reviewed Extrapolated Overpayments in the Provider Appeals Process

  

• CMS Encounter Data Lack Essential Information That Medicare Advantage Organizations Have the Ability to Collect

  

• Indiana Properly Reported Adjustments Related to the Drug Rebate Program